Letter to the editor: Comments on 'A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica'

Eur J Cancer. 2019 Apr:111:59-60. doi: 10.1016/j.ejca.2018.11.034. Epub 2019 Feb 28.

Authors

David F L Liew¹, Claire E Owen², Russell R C Buchanan²

Affiliations

¹ Department of Rheumatology, Austin Health, Melbourne, Australia; Department of Clinical Pharmacology and Therapeutics, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia. Electronic address: david.liew@austin.org.au.
² Department of Rheumatology, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.

PMID: 30826657
DOI: 10.1016/j.ejca.2018.11.034

No abstract available

Publication types

Letter
Comment

MeSH terms

Anemia, Hemolytic, Autoimmune*
Antibodies, Monoclonal, Humanized
Giant Cell Arteritis*
Humans
Polymyalgia Rheumatica*

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab